Furthermore, metformin was able to attenuate IBD severity and reduce inflammation through the regulation of Il17 and Foxp3 expression, demonstrating the importance of the Th17/Treg balance in the regulation of intestinal inflammation [Table 1; (40)]. Here, IL17A is linked to inflammatory bowel disease.